| Pomalidomide Zentiva |
Human |
pomalidomide |
Pomalidomide |
EMEA/H/C/006294 |
Zentiva, k.s. |
2024/07/24
|
Authorised |
| Ixchiq |
Human |
Chikungunya vaccine (live) |
Chikungunya virus, strain CHIKV LR2006-OPY1, live attenuated |
EMEA/H/C/005797 |
Valneva Austria GmbH |
2024/06/28
|
Authorised |
| Obgemsa |
Human |
vibegron |
vibegron |
EMEA/H/C/005957 |
Pierre Fabre Medicament |
2024/06/27
|
Authorised |
| Eribulin Baxter |
Human |
eribulin |
Eribulin mesylate |
EMEA/H/C/006191 |
Baxter Holding B.V. |
2024/06/27
|
Authorised |
| Tocilizumab STADA (previously Tofidence) |
Human |
tocilizumab |
tocilizumab |
EMEA/H/C/005984 |
STADA Arzneimittel AG |
2024/06/20
|
Authorised |
| Wezenla |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/006132 |
Amgen Technology (Ireland) UC |
2024/06/20
|
Authorised |
| Fruzaqla |
Human |
fruquintinib |
fruquintinib |
EMEA/H/C/005979 |
Takeda Pharmaceuticals International AG Ireland |
2024/06/20
|
Authorised |
| Altuvoct |
Human |
efanesoctocog alfa |
Efanesoctocog alfa |
EMEA/H/C/005968 |
Swedish Orphan Biovitrum AB (publ) |
2024/06/17
|
Authorised |
| Truqap |
Human |
capivasertib |
capivasertib |
EMEA/H/C/006017 |
AstraZeneca AB |
2024/06/17
|
Authorised |
| Fluenz |
Human |
influenza vaccine (live attenuated, nasal) |
influenza virus A/Victoria/4897/2022 (H1N1)pdm09 - like strain (A/Norway/31694/2022, MEDI 369815), A A/Croatia/10136RV/2023 (H3N2)-like strain (A/Perth/722/2024, MEDI 392611) B/Austria/1359417/2021 - like strain (B/ Austria/1359417/2021, MEDI 355292) |
EMEA/H/C/006514 |
AstraZeneca AB |
2024/06/03
|
Authorised |
| Agilus |
Human |
dantrolene sodium, hemiheptahydrate |
dantrolene sodium, hemiheptahydrate |
EMEA/H/C/006009 |
Norgine B.V. |
2024/05/29
|
Authorised |
| Qalsody |
Human |
tofersen |
tofersen |
EMEA/H/C/005493 |
Biogen Netherlands B.V. |
2024/05/29
|
Authorised |
| Neoatricon |
Human |
dopamine hydrochloride |
dopamine hydrochloride;Dopamine |
EMEA/H/C/006044 |
BrePco Biopharma Limited |
2024/05/27
|
Authorised |
| Lytenava |
Human |
bevacizumab |
bevacizumab |
EMEA/H/C/005723 |
Outlook Therapeutics Limited |
2024/05/27
|
Authorised |
| Fabhalta |
Human |
iptacopan |
iptacopan hydrochloride monohydrate |
EMEA/H/C/005764 |
Novartis Europharm Limited |
2024/05/17
|
Authorised |
| Awiqli |
Human |
insulin icodec |
insulin icodec |
EMEA/H/C/005978 |
Novo Nordisk A/S |
2024/05/17
|
Authorised |
| Wyost |
Human |
denosumab |
denosumab |
EMEA/H/C/006378 |
Sandoz GmbH |
2024/05/17
|
Authorised |
| Jubbonti |
Human |
denosumab |
denosumab |
EMEA/H/C/005964 |
Sandoz GmbH |
2024/05/16
|
Authorised |
| Omlyclo |
Human |
omalizumab |
omalizumab |
EMEA/H/C/005958 |
Celltrion Healthcare Hungary Kft. |
2024/05/16
|
Authorised |
| Emblaveo |
Human |
aztreonam;avibactam |
avibactam;aztreonam |
EMEA/H/C/006113 |
Pfizer Europe MA EEIG |
2024/04/22
|
Authorised |